A Pan-Cancer Analysis of Predictive Methylation Signatures of Response to Cancer Immunotherapy

Recently, tumor immunotherapy based on immune checkpoint inhibitors (ICI) has been introduced and widely adopted for various tumor types. Nevertheless, tumor immunotherapy has a few drawbacks, including significant uncertainty of outcome, the possibility of severe immune-related adverse events for p...

Descripción completa

Detalles Bibliográficos
Autores principales: Xu, Bingxiang, Lu, Mingjie, Yan, Linlin, Ge, Minghui, Ren, Yong, Wang, Ru, Shu, Yongqian, Hou, Lin, Guo, Hao
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Frontiers Media S.A. 2021
Materias:
Immunology
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8695566/
https://www.ncbi.nlm.nih.gov/pubmed/34956232
http://dx.doi.org/10.3389/fimmu.2021.796647

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8695566/
https://www.ncbi.nlm.nih.gov/pubmed/34956232
http://dx.doi.org/10.3389/fimmu.2021.796647

Ejemplares similares